These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 17509297)

  • 1. Guideline for the management of clinically localized prostate cancer: 2007 update.
    Thompson I; Thrasher JB; Aus G; Burnett AL; Canby-Hagino ED; Cookson MS; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen CM;
    J Urol; 2007 Jun; 177(6):2106-31. PubMed ID: 17509297
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Bartkowiak D
    Aktuelle Urol; 2016 Feb; 47(1):22-4. PubMed ID: 26903117
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate-specific antigen levels after radical prostatectomy versus brachytherapy.
    Merrick GS; Butler WM; Grimm PD
    Urology; 1999 Apr; 53(4):865-6. PubMed ID: 10197879
    [No Abstract]   [Full Text] [Related]  

  • 5. Brachytherapy or radical prostatectomy: is there a preferred method for treating localized prostate cancer?
    Stone NN
    BJU Int; 2004 Jan; 93(1):5. PubMed ID: 14678357
    [No Abstract]   [Full Text] [Related]  

  • 6. Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus.
    Levinson A; Nagler EA; Lowe FC
    Urology; 2005 Jan; 65(1):91-4. PubMed ID: 15667871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of advanced prostate cancer: a multidisciplinary team approach.
    Bellmunt Molins J; Gelabert i Mas A
    Expert Rev Anticancer Ther; 2007 Jul; 7(7):977-9. PubMed ID: 17627457
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prostatectomy, brachytherapy, percutaneous irradiation. Which method helps your patients the most?].
    Messer PM; Gottfried HW; Hautmann R; Röttinger EM
    MMW Fortschr Med; 2002 Jan; 144(1-2):39-41. PubMed ID: 11847880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy for pathologic stage C prostate cancer: a casualty of the PSA revolution?
    Anscher MS
    Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):745-7. PubMed ID: 8621301
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatments of prostate carcinoma and imaging follow up].
    Roy C; Servois V; Sauer B
    J Radiol; 2006 Feb; 87(2 Pt 2):244-56. PubMed ID: 16484949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multidisciplinary approach in the treatment of localized forms of cancer of the prostate].
    Bolla M
    Cancer Radiother; 2000 Nov; 4 Suppl 1():105s-108s. PubMed ID: 11194946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are bone scans necessary in men with low prostate specific antigen levels following localized therapy?
    Warren KS; Chodak GW; See WA; Iverson P; McLeod D; Wirth M; Morris C; Armstrong J
    J Urol; 2006 Jul; 176(1):70-3; discussion 73-4. PubMed ID: 16753371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing and treating patients with increasing prostate specific antigen following radical prostatectomy.
    Sandler HM; Eisenberger MA
    J Urol; 2007 Sep; 178(3 Pt 2):S20-4. PubMed ID: 17644123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of stage T1b (A2) and stage T1c adenocarcinoma of the prostate.
    Konety BR; Bahnson RR
    Semin Urol Oncol; 1996 Aug; 14(3):183-94. PubMed ID: 8865482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of localised prostate cancer: inform patients about adverse effects.
    Prescrire Int; 2012 Oct; 21(131):247. PubMed ID: 23185851
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase II trial of gefitinib in patients with rising PSA following radical prostatectomy or radiotherapy.
    Joensuu G; Joensuu T; Nupponen N; Ruutu M; Collan J; Pesonen S; Hemminki A
    Acta Oncol; 2012 Jan; 51(1):130-3. PubMed ID: 22150168
    [No Abstract]   [Full Text] [Related]  

  • 17. Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001).
    Villers A; Pommier P; Bataillard A; Fervers B; Bachaud JM; Berger N; Bertrand AF; Bouvier R; Brune D; Daver A; Fontaine E; Haillot O; Lagrange JL; Molinie V; Muratet JP; Pabot du Chatelard P; Peneau M; Prapotnich D; Ravery V; Richaud P; Rossi D; Soulie M; ;
    Br J Cancer; 2003 Aug; 89 Suppl 1(Suppl 1):S50-8. PubMed ID: 12915903
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current controversies in the treatment of localized prostate cancer].
    Bischoff R; Chaloupka M; Westhofen T; Grimm T; Schlenker B; Weinhold P; Tilki D; Stief CG; Kretschmer A
    Urologe A; 2019 May; 58(5):524-528. PubMed ID: 30859231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.
    Gleave ME; Goldenberg SL; Jones EC; Bruchovsky N; Sullivan LD
    J Urol; 1996 Jan; 155(1):213-9. PubMed ID: 7490838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer update.
    Rosenberg J; Small EJ
    Curr Opin Oncol; 2003 May; 15(3):217-21. PubMed ID: 12778015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.